Guardian Pharmacy Services, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Guardian Pharmacy Services, Inc. (GRDN), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are GRDN insiders buying or selling?
In the last 12 months, Guardian Pharmacy Services, Inc. insiders reported 1 open-market purchase ($99.8K) and 9 sales ($419.3M) — net selling of $419.2M. Since October 2024, Trabud has recorded 24 Form 4 filings for GRDN: 6 buys ($948.3K) and 18 sells ($757.8M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $99.8K by Steven D Cosler (Director) on Dec 5, 2025. SEC ↗
- The most recent open-market purchase was reported on Dec 5, 2025 (10 months ago).
Key Statistics (October 2024 – Mar 24, 2026)
Total Form 4 filings
24
SEC EDGAR
Insider filers
12
Insider buys (6)
$948.3K
Insider sells (18)
$757.8M
Insider sentiment
Net sellingNet insider flow of $756.8M in net selling since October 2024, and $419.2M in net selling over the last 12 months.
Recent GRDN insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | Pharmacy Investors, LLC | Other | Sale | 827.6K | $29.68 | $24.6M | SEC ↗ |
| Mar 24, 2026 | David K Morris | Executive Vice President and Chief Financial Officer | Sale | 187.9K | $29.68 | $5.6M | SEC ↗ |
| Mar 24, 2026 | Fred Burke | President and Chief Executive Officer | Sale | 671.4K | $29.68 | $19.9M | SEC ↗ |
| Mar 24, 2026 | Kendall Forbes | Executive Vice President, Sales & Operations | Sale | 346.7K | $29.68 | $10.3M | SEC ↗ |
| Mar 24, 2026 | Cardinal Equity Fund, L.P. | Other | Sale | 275.7K | $29.68 | $8.2M | SEC ↗ |
| Mar 24, 2026 | Thomas J Salentine Jr | Director, 10% Owner | Sale | 3.6M | $29.68 | $106.0M | SEC ↗ |
| Mar 24, 2026 | Bindley Capital Partners I, LLC | 10% Owner | Sale | 3.6M | $29.68 | $106.0M | SEC ↗ |
| Mar 24, 2026 | John Ackerman | Director | Sale | 1.1M | $29.68 | $32.8M | SEC ↗ |
| Mar 24, 2026 | BINDLEY WILLIAM E | Director, 10% Owner | Sale | 3.6M | $29.68 | $106.0M | SEC ↗ |
| Dec 5, 2025 | Steven D Cosler | Director | Purchase | 3.4K | $29.61 | $99.8K | SEC ↗ |
| Sep 30, 2025 | Cardinal Equity Fund, L.P. | Other | Sale | 321.3K | $20.16 | $6.5M | SEC ↗ |
| Sep 30, 2025 | Pharmacy Investors, LLC | Other | Sale | 964.3K | $20.16 | $19.4M | SEC ↗ |
| May 29, 2025 | BINDLEY WILLIAM E | Director, 10% Owner | Sale | 4.2M | $20.16 | $83.9M | SEC ↗ |
| May 29, 2025 | Thomas J Salentine Jr | Director, 10% Owner | Sale | 4.2M | $20.16 | $83.9M | SEC ↗ |
| May 29, 2025 | John Ackerman | Director | Sale | 1.3M | $20.16 | $25.9M | SEC ↗ |
| May 29, 2025 | David K Morris | Executive Vice President and Chief Financial Officer | Sale | 437.8K | $20.16 | $8.8M | SEC ↗ |
| May 29, 2025 | Fred Burke | President and Chief Executive Officer | Sale | 885.8K | $20.16 | $17.9M | SEC ↗ |
| May 29, 2025 | Kendall Forbes | Executive Vice President, Sales & Operations | Sale | 415.0K | $20.16 | $8.4M | SEC ↗ |
| May 29, 2025 | Bindley Capital Partners I, LLC | 10% Owner | Sale | 4.2M | $20.16 | $83.9M | SEC ↗ |
| Nov 20, 2024 | Steven D Cosler | Director | Purchase | 7.0K | $21.22 | $148.5K | SEC ↗ |
| Oct 1, 2024 | Thomas J Salentine Jr | Director | Purchase | 35.7K | $14.00 | $500.0K | SEC ↗ |
| Oct 1, 2024 | Mary Sue Patchett | Director | Purchase | 3.6K | $14.00 | $50.0K | SEC ↗ |
| Oct 1, 2024 | Randall J Lewis | Director | Purchase | 3.6K | $14.00 | $50.0K | SEC ↗ |
| Oct 1, 2024 | Steven D Cosler | Director | Purchase | 7.1K | $14.00 | $100.0K | SEC ↗ |
Showing the 24 most recent of 24 Form 4 filings for Guardian Pharmacy Services, Inc..
Most active GRDN insiders
- Steven D Cosler3 filings
- Thomas J Salentine Jr3 filings
- Bindley Capital Partners I, LLC2 filings
- BINDLEY WILLIAM E2 filings
- Cardinal Equity Fund, L.P.2 filings
Ask anything about GRDN insider activity
Use Trabud's AI agent to query Guardian Pharmacy Services, Inc.'s Form 4 history in plain English — "Show me GRDN CEO purchases this year" or compare it against any other ticker.
Open the AI agentGRDN insider trading FAQ
Are Guardian Pharmacy Services, Inc. insiders buying or selling?
In the last 12 months, Guardian Pharmacy Services, Inc. insiders reported 1 open-market purchase ($99.8K) and 9 sales ($419.3M) — net selling of $419.2M. Since October 2024, Trabud has recorded 24 Form 4 filings for GRDN: 6 buys ($948.3K) and 18 sells ($757.8M). Over the full record that is net selling of $756.8M.
How many insiders trade GRDN stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Guardian Pharmacy Services, Inc.. The most recent filing was accepted on Mar 24, 2026.
Where does Trabud get GRDN insider trading data?
All GRDN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.